EVITOL 100 MG

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Nopērc to tagad

Aktīvā sastāvdaļa:

TOCOPHEROL (VIT E) (AS TOCOPHERYL ACETATE)

Pieejams no:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATĶ kods:

A11HA03

Zāļu forma:

TABLETS

Kompozīcija:

TOCOPHEROL (VIT E) (AS TOCOPHERYL ACETATE) 100 MG

Ievadīšanas:

PER OS

Receptes veids:

Not required

Ražojis:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Ārstniecības grupa:

TOCOPHEROL (VIT E)

Ārstniecības joma:

TOCOPHEROL (VIT E)

Ārstēšanas norādes:

For the prevention and treatment of diseases caused by Vitamin E deficiency.

Autorizācija datums:

2012-12-31

Produkta apraksts

                                Evitol Tablets, 1 4. 2014, RH
"
ע עבקנ הז ןולע טמרופ
"
רשואו קדבנ ונכותו תואירבה דרשמ י
."
רשואמ ןולע
:
31/3/2014
“This leaflet form
at has been determined by the Ministry of Health and the content
thereof has
been checked and approved.” Date of approval: 31/3/2014
EVITOL
®
TABLETS
COMPOSITION
Each tablet contains:
_Active Ingredient _
dl-alpha-Tocopherol acetate 100 mg or 200 mg (Vitamin E)
_Other Ingredients _
Microcrystalline cellulose, silicon dioxide, hydrogenated vegetable
oil, povidone,
gelatin, sucrose
*
, maize starch, sodium alumino-silicate.
*
_Each Evitol 100 mg tablet contains 9.4 mg sucrose_.
_* Each Evitol 100 mg tablet contains 1.74 mg sodium. _
_ _
_*_
_ Each Evitol 200 mg tablet contains 18.8 mg sucrose. _
_* Each Evitol 200 mg tablet contains 3.5 mg sodium. _
_ _
MECHANISM OF ACTION
Vitamin E is a fat-soluble intracellular antioxidant. It plays an
important role in
preventing
oxidation
of
essential
cellular
constituents,
thereby
preventing
the
formation of toxic oxidation products, such as the peroxides formed
from unsaturated
fatty acids. These lipid peroxides are known to damage cell membranes.
Vitamin E deficiency plays a significant role in the pathogenesis of
hemolytic anemia
in premature infants. Its antioxidant property is important for the
maintenance of red
cell viability. It is also quite likely that vitamin E deficiency
predisposes to the
development of retrolental fibroplasia in premature infants exposed to
higher oxygen
tensions than those of the intrauterine environment.
The need of the body for vitamin E is considerably increased by diets
that contain
foods rich in polyunsaturated fatty acids. This explains vitamin E
deficiency in infants
fed
on
formulas
rich
in
such
fatty
acids.
This
deficiency
is
corrected
by
the
administration of vitamin E. In fact, it has been shown that levels of
vitamin E rise
much slower in artificially-fed infants than in those who are
breastfed.
Human atheromatous lesions contain lipid peroxides. F
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija ivrits 17-08-2016

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi